Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO Italy 2022 | Exciting research in the CAR-T space: the promise of allogeneic therapies

Massimiliano Mazza • 25 Oct 2022
SOHO Italy 2022
General CAR-T NK-Cell Therapy

Massimiliano Mazza, PhD, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), Meldola, Italy, briefly comments on the promise of allogeneic therapies and how these may reduce common toxicities associated with CAR-T therapy, including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). This interview took place at the 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Massimiliano Mazza

2:22
Insights into the ‘Alleanza Contro il Cancro’ and its CAR-T project
Massimiliano Mazza • 25 Oct 2022

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals